Immunotherapy in cervix cancer

Incidence and mortality of cervical cancer in developed countries have both decreased since the introduction of Pap test and screening campaigns in the 1940s, thanks to an earlier diagnosis [1]. Nevertheless, cervical cancer is still one of the most common malignancies in the female population worldwide, with higher risk for socioeconomic disadvantaged groups, and a poor prognosis for advanced disease [2-4].

Source: Cancer Treatment Reviews - August 6, 2020 Category: Cancer & Oncology Authors: Laura Attademo, Valentina Tuninetti, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Rosa Tambaro, Giorgio Valabrega, Lucia Musacchio, Sergio Venanzio Setola, Patrizia Piccirillo, Daniela Califano, Anna Spina, Simona Losito, Stefano Greggi, San Source Type: research